Termination of exercise (Option: to continue until sufficient consensus on a mutual policy is reached).
Injection of 700 MBq99mTc-sestamibi was given at peak exercise level one minute prior to termination of exercise.
Telemetry ECG recordings and measurements were made at rest, after 10 and 20 minutes of exercise, just before termination of exercise, and at recovery.
A minimum 5 min recovery period follows termination of exercise.
Total metabolic equivalents (METS) achieved, 'Heart-rate recovery' 1 min after termination of exercise.
Termination of exercise was based on attainment of 80 93% of maximal predicted heart rate and the tolerance of each individual.
Of note, however, not only the extent, but also the nature of the neuromuscular fatigue induced by the constant-load exercise was similar at the termination of exercise.
Post hoc analysis displayed significantly higher subjective DOMS for the 3 days following exercise compared to the termination of exercise (F1,9 > 35, P < 0.001, for both scales).
In this study, termination of exercise was based on the attainment of 80 93% of the maximal predicted heart rate and the tolerance of each individual.
The test was terminated when the subject reached VO2max[ 41, 42] or showed any symptoms that indicated termination of exercise based on the guidelines of the American College of Sports Medicine [ 43].
Before exercise, at the end of each 3-min exercise bout and 5-min after termination of exercise, blood samples were taken for determination of the plasma concentrations of ADM, NA, A, ET-1 and PRA.
